SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-240517
Filing Date
2021-08-09
Accepted
2021-08-09 16:34:31
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d172084d10q.htm   iXBRL 10-Q 1176978
2 EX-31.1 d172084dex311.htm EX-31.1 10222
3 EX-31.2 d172084dex312.htm EX-31.2 10207
4 EX-32.1 d172084dex321.htm EX-32.1 4064
5 EX-32.2 d172084dex322.htm EX-32.2 4070
  Complete submission text file 0001193125-21-240517.txt   5436772

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210630.xsd EX-101.SCH 43423
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20210630_cal.xml EX-101.CAL 44411
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20210630_def.xml EX-101.DEF 170508
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210630_lab.xml EX-101.LAB 343020
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210630_pre.xml EX-101.PRE 276454
11 EXTRACTED XBRL INSTANCE DOCUMENT d172084d10q_htm.xml XML 917460
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 211157009
SIC: 2834 Pharmaceutical Preparations